New patent for Neurocrine drug ONGENTYS

Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting…

Source


Comments are closed.

Biotechblog